Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

CSTONE PHARMA-B(02616.HK)

Event Tracking

Apr14

Chi-Med Starts Private Placement to Raise HK$1.1B for R&D

23:08

Apr8

CMBI Raises Target Price for Chi-Med

02:52

Mar31

CStone Pharma Reports Expanding Losses but Sees Stock Surge with New Drug Clinical Data

18:11

Goldman Sachs Maintains Buy Rating on Chi-Med and Sets Price Target

09:36

Mar30

International investment institutions give positive evaluations on CStone's core product CS2009

01:25

Mar26

CSTONE PHARMA-B released FY2025 9 Months Earnings on March 26 (BJT), actual revenue HKD 173.86 M, actual EPS HKD -0.2897

15:00

Schedules & Filings

Schedules

Filings

Mar26

Earning Release(CST)

FY2025 Q4 Earning Release (HKD) Revenue 122.4 M, Net Income -92.75 M, EPS -0.0634

Aug14

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 27.06 M, Net Income -147.86 M, EPS -0.1149

Mar27

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 81.41 M, Net Income -56.87 M, EPS -0.0445

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

CSTONE PHARMA-B(02616.HK)

CSTONE PHARMA-B Stock Performance Chart